News

Healthcare costs are expected to rise by nearly 8% in 2025 ... In addition, more people are using GLP-1 weight loss drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, to treat diabetes, obesity ...
Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...
The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...
The following is a special feature from CivicScience CEO and Founder John Dick. Learn how you can turn insights like these ...
The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...
The first significant rift within MAGA under Trump 2.0 emerged with the passage of the Big Beautiful Bill, which extended the ...
A mother-of-three who shed two stone in just nine weeks thanks to a skinny jab has warned users of a painful side-effect that ...
Sustainability awareness remains strong in the Middle East, with 75% of respondents expressing concern about climate change.
Novo Nordisk, PayPal, and Dell Technologies are modestly priced growth stocks with a lot of potential to rise higher. Buying ...
The Secretary of Health Services wants every American to use a wearable device in the next four years. Experts say it's a ...
The preventative healthcare measures recommended in the Scotland’s Population Health Framework 2025-2035 plan have been ...
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...